Trinseo (NYSE: TSE), the global materials company and manufacturer of plastics, latex binders and synthetic rubber, will showcase its plastics and highlight its recent ISO 13485 achievement at MD&M West 2017 in Anaheim, California. The company will exhibit at Booth 538 in Hall E for the duration of the show, which runs from February 7- 9, 2017.
Trinseo has supported the medical device industry for almost three decades. The company is focused on providing high quality custom polycarbonate, ABS and polystyrene compounds consistently and reliably. Its recent ISO 13485:2016 certification furthers this commitment and addresses the imperatives of quality, risk management and speed to market that are so important to medical device customers.
Trinseo’s focus at MD&M West is on its MAGNUM™ ABS Resins and EMERGE™ Advanced Resins for applications including drug delivery devices (e.g., inhalers, insulin pens, nebulizers, etc.) as well as equipment housings. The company’s ABS offers the advantage of mass polymerization technology resulting in lower residual monomers, exceptional purity, brilliant whiteness, and lot-to-lot consistency.
The Company’s other flagship products to be featured at the show include CALIBRE™ Polycarbonate Resins and CALIBRE™ MEGARAD™ Polycarbonate resins, Trinseo’s color-stabilized grades for applications needing to be sterilized. The company also will highlight its biocompatible ISO 10993-compliant glass-filled resins with varying percentages of glass content for applications needing structural strength.
To arrange a meeting with Trinseo onsite at MD&M West 2017 contact Paula Biskup, global business communications manager.
Trinseo (NYSE:TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber with a focus on delivering innovative, sustainable, and value-creating products that are intrinsic to our daily lives. Trinseo is dedicated to making a positive impact on society by partnering with like-minded stakeholders, and supporting the sustainability goals of our customers in a wide range of end-markets including automotive, consumer electronics, appliances, medical devices, packaging, footwear, carpet, paper and board, building and construction, and tires. Trinseo had approximately $3.0 billion in net sales in 2020, with 17 manufacturing sites around the world, and approximately 2,600 employees. For more information, please visit: www.trinseo.com.
Cautionary Note on Forward-Looking Statements
This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding the timing of the proposed acquisition of the Arkema MMA and PMMA business (the "Acquisition"); estimated and future results of operations, business strategies, competitive position, industry environment and potential growth opportunities and cost synergies relating to the Acquisition, our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause such a difference include, but are not limited to, our failure to complete the Acquisition or meet the conditions to closing, including antitrust, works council and other regulatory approvals; the failure to obtain the financing necessary to fund the Acquisition and the impact of the substantial indebtedness to be incurred; costs related to the Acquisition; following the Acquisition, our ability to successfully integrate the acquired businesses, generate expected cost savings and synergies, maintain relationships with customers, retain key employees and profitably grow the business; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.